Advertisement

Pathology

Home Pathology

‘Superbug’ Fungus Spreads Among Vulnerable in Two U.S. Cities

There were 101 Candida auris cases at a nursing home and 22 cases at hospitals from January to April

Intracoronary administration of nicardipine seems to be highly effective in reversing spontaneous coronary slow-flow

IC Nicardipine Promising for Tx of Spontaneous Coronary Slow-Flow

Administration of intracoronary nicardipine results in markedly accelerated coronary filling

Adenoma Detection Rate Tied to CRC Risk After Positive FIT

ADR of endoscopists inversely associated with the risk for interval postcolonoscopy CRC in FIT-positive individuals

Vitamin D deficiency may be associated with increased neuropathic pain in patients with rheumatoid arthritis

Vitamin D Deficiency Tied to Neuropathic Pain

Findings among patients diagnosed with rheumatoid arthritis
Changes to cervical cancer screening guidelines in Canada in 2012 correlated with reductions in chlamydia testing and decreases in reported incidence of chlamydia in females

Change to Cervical Screening Guidelines Impacted Chlamydia

Reduction in chlamydia testing, drop in reported incidence of chlamydia after changes in screening

Increased Morbidity Risks Seen for Male, Female p.C282Y Homozygotes

Increased risks seen for those with baseline hemochromatosis diagnoses and for those undiagnosed with hemochromatosis

The U.S. Food and Drug Administration approved on Thursday a Massachusetts company's request to produce genetically modified salmon.

FDA Grants Approval for Genetically Engineered Salmon

Agency says it's safe to eat and doesn't need special label
Two novel loci have been identified that are associated with insulin sensitivity

Study IDs Two Novel Loci Linked to Insulin Sensitivity

Associations for BCL2 and FAM19A2 were independent of known cardiometabolic loci
SERPINA1 DNA sequencing can identify alpha-1 antitrypsin deficiency

DNA Sequencing Identifies Alpha-1 Antitrypsin Deficiency

Six rare mutations identified in seven subjects that would not have been uncovered without sequencing
Only half of oncologists who discuss genomic testing with patients report that they often discuss the likely costs of testing and related treatments

Many Oncologists Fail to Discuss Costs of Genomic Testing

About a quarter of oncologists say they rarely, never bring up costs when they discuss genomic testing